| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| ADD | acceptable daily dose; adduction; adenosine deaminase; attentional deficit disorder; average daily d... |
| ADI | Academy of Dentistry International; acceptable daily intake; AIDS-defining illness; allowable daily ... |
| DRF | Daily Rating Form; daily replacement factor; Deafness Research Foundation; dose reduction factor |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| ECGS | Endothelial Cell Growth Supplement |
|---|---|
| lactase | Beta-galactosidase |
| L | Lactase |
| LPH | Lactase phlorizin hydrolase |
| ADI | Acceptable Daily Intake |
naso-oral
| supplement | Something that supplies a want or make an addition: something that completes, adds a finishing touch or brings closer to completion or a desired state. (18 Nov 1997) |
|---|---|
| acceptable daily intake | <pharmacology> This is an estimate of the amount of a substance in food that can be ingested daily over a lifetime by humans without appreciable health risk. The concept of the acceptable daily intake has been developed principally by who and FAO and is relevant to chemicals such as additives to foods, residues of pesticides and veterinary drugs in foods. Acceptable daily intakes are derived from laboratory toxicity data, and from human experiences of such chemicals when this is available, and incorporate a safety factor. The acceptable daily intake is thus an estimate of the amount of a substance in food that can be ingested over a lifetime by humans without significant risk to health (for contaminants in food and drinking water, tolerable intakes - daily or weekly - are used). See: tolerable daily intake. (15 Jan 1998) |
| activities of daily living | The things we normally do in daily living including any daily activity we perform for self-care (such as feeding ourselves, bathing, dressing, grooming), work, homemaking, and leisure. The ability or inability to perform ADLs can be used as a very practical measure of ability/disability in many disorders. (12 Dec 1998) |
| activities of daily living scale | A scale to score physical activity and its limitations, based on answers to simple questions about mobility, self-care, grooming, etc; widely used in geriatrics, rheumatology, etc. (05 Mar 2000) |
| daily dose | The total amount of a remedy that is to be taken within 24 hours. (05 Mar 2000) |
| tolerable daily intake | TDIs are applied to chemical contaminants in food and drinking water. The presence of contaminants is unwanted and they have no useful function, differing from additives and residues where there is or was deliberate use resulting in their presence. TDIs are calculated on the basis of laboratory toxicity data with the application of uncertainty factors. A TDI is therefore an estimate of the amount of a substance (contaminant) in food or drinking water that can be ingested daily over a lifetime without a significant health risk. (09 Oct 1997) |
| adult lactase deficiency | Onset of lactase deficiency, with resulting milk intolerance and malabsorption, in adulthood. Inherited forms may not be manifested until adulthood; any process that damages the intestinal lining cells can cause lactase deficiency in adults. (05 Mar 2000) |
| pro-lactase-phlorizin hydrolase | <chemical> Synonym: pro-lph (26 Jun 1999) |
| deficiency, lactase | Lack of the enzyme lactase resulting in failure to digest lactose in milk (lactose intolerance). (12 Dec 1998) |
| lactase | Enzyme that breaks down the milk sugar lactose. (12 Dec 1998) |
| lactase deficiency | An intolerance to milk and dairy products due to a deficiency of lactase in the intestine. Lactase is a enzyme which breaks down milk sugar or lactose. This condition is common in adults and may affect as many as 70-90% of Asians, African Americans, Native Americans and Mediterranean populations. This condition may also develop as the result of an intestinal disease such as celiac sprue. Symptoms include abdominal cramps, bloating, nausea, weight loss and diarrhoea. Treatment involves removing milk products from the diet. For infant's see Lactofree or ProSobee. (27 Sep 1997) |
| lactase restriction | An inherited trait in which there is low lactase activity and thus there is defective lactose intestinal metabolism. Compare: lactase persistence. (05 Mar 2000) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|